Clinical Trial TitleProspective, open-label multicenter phase 3b to assess the efficacy and safety of personalized prophylaxis with Human-cl rh-FVIII in previously treated adult with severe hemophilia A.
Clinical Trial Protocol Description:
Prophylaxis infusion with PK studies.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have severe hemophilia A.
- Are male and at least 18 years of age.
This is a partial list of elgibility requirements.